Adrian M Di Bisceglie

ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 8

Top Venues

Alimentary pharmacology & therapeutics

Journal of gastroenterology and hepatology

Hepatology (Baltimore, Md.)

Nature communications

Saint Louis University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Saint Louis University

United States

Chairman :: Internal Medicine

Publications

Anna Fettiplace, John Marcinak, Michael Merz, Hui-Talia Zhang, Luciana Kikuchi, Arie Regev, Melissa Palmer, Don C Rockey, Robert Fontana, Paul H Hayashi, Hans L Tillmann, Adrian M Di Bisceglie, James H Lewis
Review article: Recommendations for detection, assessment and management of suspected drug-induced liver injury during clinical trials in oncology patients. Alimentary pharmacology & therapeutics (2024)
David E Kleiner, Mauricio Lisker-Melman, Abdus S Wahed, Atul K Bhan, Michael A Nalesnik, Eun-Young K Choi, Kelsey K Leonard, Marc G Ghany, Raymond T Chung, Adrian M Di Bisceglie
Immunostaining for Hepatitis B Viral Antigens in Liver: Association with Clinical, Biochemical and Virologic Features of Disease. Journal of gastroenterology and hepatology (2023)
Adrian M Di Bisceglie
Editorial: Feeling better about NASH. Alimentary pharmacology & therapeutics 58 (4) (2023)
Stephen A Harrison, Nadege Gunn, Guy W Neff, Anita Kohli, Liping Liu, Abbey Flyer, Lawrence Goldkind, Adrian M Di Bisceglie
A phase 2, proof of concept, randomised controlled trial of berberine ursodeoxycholate in patients with presumed non-alcoholic steatohepatitis and type 2 diabetes. Nature communications 12 (1) (2021)
Anna S Lok, Robert Perrillo, Christina M Lalama, Michael W Fried, Steven H Belle, Marc G Ghany, Mandana Khalili, Robert J Fontana, Richard K Sterling, Norah A Terrault, Jordan J Feld, Adrian M Di Bisceglie, Daryl T Y Lau, Mohamed Hassan, Harry L A Janssen, null null
Low Incidence of Adverse Outcomes in Adults With Chronic Hepatitis B Virus Infection in the Era of Antiviral Therapy. Hepatology (Baltimore, Md.) 73 (6) (2021)
Adrian M Di Bisceglie, Gerald F Watts, Philip Lavin, Meng Yu, Ru Bai, Liping Liu
Pharmacokinetics and pharmacodynamics of HTD1801 (berberine ursodeoxycholate, BUDCA) in patients with hyperlipidemia. Lipids in health and disease 19 (1) (2020)
Adrian M Di Bisceglie, Wendy C King, Mauricio Lisker-Melman, Mandana Khalili, Steven H Belle, Jordan J Feld, Marc G Ghany, Harry L A Janssen, Daryl Lau, William M Lee, Simon C Ling, Stewart Cooper, Philip Rosenthal, Kathleen B Schwarz, Richard K Sterling, Jeffrey H Teckman, Norah Terrault, null null
Age, race and viral genotype are associated with the prevalence of hepatitis B e antigen in children and adults with chronic hepatitis B. Journal of viral hepatitis 26 (7) (2019)
Young-Chan Kwon, Hangeun Kim, Keith Meyer, Adrian M Di Bisceglie, Ranjit Ray
Distinct CD55 Isoform Synthesis and Inhibition of Complement-Dependent Cytolysis by Hepatitis C Virus. Journal of immunology (Baltimore, Md. : 1950) 197 (4) (2016)

Adrian M Di Bisceglie.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Adrian M Di Bisceglie